Lenzilumab (Anti-CSF2 / GM-CSF)

Lenzilumab (Anti-CSF2 / GM-CSF) is a recombinant monoclonal antibody against the cytokine granulocyte macrophage colony-stimulating factor (GM-CSF), with potential immunomodulating activity. MW: 145.72 KD.
Supplier Selleck Chemicals
Product # A2854
Sku # A2854-1mg
Pricing 1mg, $370.00
Feedback